Figure 3.
Immunoprofiles in acute-phase (n = 131) and remission (n = 50) samples. The immunoprofiles were formed based on the presence or absence of anti-M, anti-DT, anti-CS, anti-T2-T5, anti-T6-T8, and anti-CUB1-2 autoantibodies. Green rectangles indicate the presence and red rectangles the absence of detectable anti-M, anti-DT, anti-CS, anti-T2-T5, anti-T6-T8, and anti-CUB1-2 autoantibodies. The immunoprofiles are listed starting with the most prevalent immunoprofiles in the acute-phase samples. Orange bars represent the number of acute-phase samples with a specific immunoprofile; blue bars represent the number of remission samples with a specific immunoprofile.

Immunoprofiles in acute-phase (n = 131) and remission (n = 50) samples. The immunoprofiles were formed based on the presence or absence of anti-M, anti-DT, anti-CS, anti-T2-T5, anti-T6-T8, and anti-CUB1-2 autoantibodies. Green rectangles indicate the presence and red rectangles the absence of detectable anti-M, anti-DT, anti-CS, anti-T2-T5, anti-T6-T8, and anti-CUB1-2 autoantibodies. The immunoprofiles are listed starting with the most prevalent immunoprofiles in the acute-phase samples. Orange bars represent the number of acute-phase samples with a specific immunoprofile; blue bars represent the number of remission samples with a specific immunoprofile.

Close Modal

or Create an Account

Close Modal
Close Modal